Texas Top Legal Officer Takes Legal Action Against Acetaminophen Makers Regarding Autism Spectrum Assertions

The top legal official in Texas Ken Paxton is suing the manufacturers of Tylenol, asserting the firms hid alleged dangers that the medication posed to pediatric brain development.

This legal action comes four weeks after Former President Trump advocated an unproven link between consuming Tylenol - also known as paracetamol - during pregnancy and autism in young ones.

Paxton is filing suit against Johnson & Johnson, which once produced the medication, the sole analgesic recommended for women during pregnancy, and Kenvue, which currently produces it.

In a statement, he said they "misled consumers by profiting off of suffering and marketing drugs regardless of the potential hazards."

The company asserts there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening countless individuals to boost earnings," the attorney general, a Republican, stated.

The manufacturer said in a statement that it was "seriously troubled by the perpetuation of misinformation on the security of acetaminophen and the possible consequences that could have on the well-being of women and children in America."

On its official site, Kenvue also mentioned it had "regularly reviewed the applicable studies and there is no credible data that shows a proven link between using paracetamol and autism."

Groups representing doctors and health professionals share this view.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in acetaminophen - is among limited choices for pregnant women to manage pain and fever, which can present major wellness concerns if not addressed.

"In multiple decades of research on the use of acetaminophen in pregnancy, no reliable research has definitively established that the use of acetaminophen in any period of gestation results in neurodevelopmental disorders in offspring," the group commented.

The court filing cites recent announcements from the Trump administration in arguing the medication is reportedly hazardous.

In recent weeks, the former president caused concern from public health officials when he told women during pregnancy to "struggle intensely" not to take acetaminophen when sick.

The US Food and Drug Administration then issued a notice that physicians should think about restricting the consumption of acetaminophen, while also stating that "a causal relationship" between the drug and autism in young ones has remains unverified.

The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in spring to conduct "a massive testing and research effort" that would establish the origin of autism spectrum disorder in a matter of months.

But experts cautioned that discovering a unique factor of autism spectrum disorder - thought by researchers to be the consequence of a complex mix of genetic and external influences - would be difficult.

Autism is a form of lifelong neurodivergence and condition that affects how people perceive and engage with the surroundings, and is recognized using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is seeking US Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the research" around paracetamol and autism spectrum disorder.

The lawsuit attempts to require the firms "remove any marketing or advertising" that states acetaminophen is secure for pregnant women.

The Texas lawsuit parallels the grievances of a collection of parents of minors with autism and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in 2022.

Judicial authorities dismissed the lawsuit, saying research from the family's specialists was lacking definitive proof.